(Q35800712)
Statements
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11 (English)
Tom Mikkelsen
Kathryn A Carson
Tracy T Batchelor
Mark R Gilbert
Jeffrey G Supko
Stuart A Grossman
Glenn J Lesser
Surasak Phuphanich
NABTT CNS Consortium
1 January 2004